BIOSYNTECH INC (OTCMKTS:BSYI) had a decrease of its shorted shares by 99%. FINRA announced shorted shares of BSYI’s total 200 shares. The 20,000 previous shares are down with 99%.

$0.0035 was the last price.Since March 5, 2018 it’s 0.00% down thus . The stock underperformed the S&P 500 by 4.37%.

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery.The company has $407,543 market cap. The Company’s lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration.Currently it has negative earnings. The company's products also comprise BST-Gel injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials.